Menu

News & events

Keep up-to-date with the latest Synthetic Biology information from across the industry


Addressing Global Challenges

Expert insights from SynbiCITE's leadership on the role of synthetic biology in solving some of the most significant challenges currently faced by our society

Read article
Evonetix makes key appointments to support development of novel gene synthesis technology

CAMBRIDGE, UK, 18 September 2018 – EVONETIX LTD (‘Evonetix’), the company pioneering an innovative approach to scalable and high-fidelity gene synthes...

Read article
Global Biofoundry Meeting, London, June 2018

A meeting was held at Imperial College London on June 21st/22nd 2018, which gathered fifteen[1]of the leading synthetic biology biofoundries from around the world to discuss current activities and exchange information on key capabilities and projects being developed by these groups.

Read article
Save the date for our first Synthetic Biology Industrial Translation Showcase

The inaugural SynbiCITE – Synthetic Biology Industrial Translation Showcase will take place on Tuesday 5th June from 9.00am-5.00pm at the Royal Academy of Engineering

Read article
Synpromics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2017

SynbiCITE congratulates Synpromics as the winner of Best Emerging UK Synthetic Biotech Company at OBN’s 9th Annual Awards.

Read article
World leading DNA technology is expanding its operations in London as it grows to meet global DNA demand

Touchlight Genetics Ltd has developed a revolutionary DNA technology that can synthetically manufacture commercial scale DNA in a two-week process – a...

Read article
Touchlight welcomes Dr. Geoff Smith

Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.

Read article
Lab automation or robotic scientists: Dr McClymont and Professor Freemont share their views in Nature Biotechnology

Dr David McClymont, head of automation at the London DNA Foundry, and Professor Paul Freemont, Co-director of the London DNA Foundry and the EPSRC Cen...

Read article
The London DNA Foundry Launches New Website

Based at Imperial College, the London DNA Foundry is a core facility at SynbiCITE, and has recently launched a new website.

Read article
LGC and Desktop Genetics receive SynbiCITE funding to develop novel methods for CRISPR genome editing analysis

Desktop Genetics and LGC have been awarded funding from SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology, to develop screening and validation tools for functional genomics, cell line engineering and synthetic biology.

Read article
First look at the latest applications for Bio-start

Applications from a range of sectors across the UK continue to arrive for Bio-start, the competition to incentivise innovative early-stage companies a...

Read article
Bio-start Announces David Lawrence as Competition Finalist Judge

SynbiCITE and Rainbow Seed Fund today announce that Dr David Lawrence, Non-executive Director at Syngenta and Chairman of the Science and Technology A...

Read article
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards

London, UK, 12th October 2018 / Sciad Newswire / SynbiCITE would like to congratulate Evonetix on winning ‘Best Emerging Synthetic Biology Company’ at...

Read article
Buildings made from fungi? Meet London’s pop-up bio-lab innovators

If there’s one place you wouldn’t expect a new biotech research lab to be built, it’s slap bang in the middle of a busy London marketFind out more her...

Read article
SynbiCITE/Synbiobeta Webinar

If you missed the webinar you can catch up here https://synbiobeta.com/synbicite-webinarThe webinar highlighted findings from SynBioBeta’s 2018 Q2 inv...

Read article
Prokarium secures $10 million investment

Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccinesKeele...

Read article
Breathing chandeliers and algae sculptures: bionic art comes to the V&A

Arborea, based in Imperial College’s White City innovation hub, has been featured in the Financial Times.

Read article
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking...

Read article
A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology

A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and rapidly growing sector of the bioeconomy.

Read article
Synpromics raises £5.2m of new investment

Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M. Participants included existing investors Calculus Capital, the Scottish Investment Bank, the investment arm of Scottish Enterprise and private shareholders.

Read article
SynbiCITE is a proud sponsor of the ‘Best Emerging UK Synthetic Biology Company’ at the OBN Awards 2017

SynbiCITE is pleased to announce once again they will be sponsoring the ‘Best Emerging UK Synthetic Biology Company’ at the 9th Annual OBN Awards, 2017. This award recognises the emerging industrial or synthetic biology company that has the most promise.

Read article
Prokarium and Probiomed in UK-Mexico Collaboration to Scale-Up Manufacture of Thermostable Vaccines with a Focus on Diarrhoea

Keele, UK and Mexico City, MX, 4th January 2017 / Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture...

Read article
SynbiCITE response to Government announcement on extra investment for science

SynbiCITE welcomes yesterday’s announcement by the Government of an additional £2billion investment per year for UK science R&D by the end of this parliament. SynbiCITE Co-Director’s Professors Richard Kitney and Paul Fremont share their thoughts.

Read article
Touchlight Genetics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2016

SynbiCITE congratulates Touchlight Genetics as the winner of Best Emerging UK Synthetic Biotech Company at the OBN’s 8th Annual Awards Ceremony held l...

Read article
SynbiCITE Join BIA Promoting UK Companies at SynBioBeta, San Francisco 2016

SynbiCITE, along with the BIA – the UK’s biotechnology trade association - is headed to San Francisco, USA, to promote the UK synthetic biology industry to their American counterparts, as well as industry leaders and investors.

Read article
Synthace launches ground-breaking new whitepaper

Comprehensive report heralds the beginning of Computer Aided Biology (CAB)LONDON October 01 2018 - Synthace Ltd., the company behind the leading cloud...

Read article
A Lloyd's Emerging Risk Report

Synthetic biology, the application of engineering principles to genetic modification is a market forecast to grow to $39bn by 2020. In recent years sc...

Read article
RebelBio | Ready to change the world with biology?

RebelBio, the world’s first early-stage life-sciences accelerator, has opened their applications for the Winter Programme. Science graduates, PhDs, po...

Read article
Transformational European Commission Grant dramatically accelerates novel biomaterial company Customem

CustoMem, founded in 2015 by two Imperial College London graduates, Henrik Hagemann and Gabi Santosa, has received a substantial €1.4m grant that will...

Read article
NPL and Imperial College London Launch a New Virtual Lab to Establish the UK Centre for Engineering Biology, Metrology and Standards

NPL, the UK's National Measurement Institute (NMI), and SynbiCITE at Imperial College London, have announced the establishment of a new £7 million virtual lab to underpin their joint Centre for Engineering Biology, Metrology and Standards to help the UK synthetic biology industry improve the manufacturing and adoption of new products - in partnership with LGC and NIBSC.

Read article
Synpromics expands facilities to meet demand for revolutionary gene control technology

Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre.

Read article
UK Synthetic Biology Start up Survey 2017

We would like to invite you to the Breakfast Seminar Launch of SynbiCITE’s UK Synthetic Biology Start-up Survey on Friday 21st July 2017, at 9.00-10:4...

Read article
Two new start-up plans win BrisSynBio’s first synthetic biology entrepreneurship competition

Two start-ups' proposals have been chosen as the winners of the first competition to discover and accelerate new synthetic biology companies at the University of Bristol.

Read article
East African Collaborations in Practical Synthetic Biology Workshop

From the 15th-17th March 2017 SynbiCITE will attend a workshop to establish UK-East African collaborations in practical synthetic biology, taking plac...

Read article
Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics

Edinburgh, UK, 4th January 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collabora...

Read article
Synbio Start-up Accelerator and Mentoring Programme

Running from February – April 2017, the Bio-start accelerator will provide direct access to connections that matter most in the industry. All entrants accepted into the programme will receive substantial mentoring and exposure to our global business and investor network.

Read article
Bio-start Confirms Sir Richard Sykes as Chair of Judging Panel

SynbiCITE and Rainbow Seed Fund today announce that Sir Richard Sykes, Chairman of the Royal Institution of Great Britain, Chairman of Imperial Colleg...

Read article
SynbiCITE launches new five-year strategy

SynbiCITE, the UK’s national centre for commercialisation of synthetic biology, launches a new five-year strategy underpinned by a new £5M grant from UKRI and other sources.

Read article
New competition - metasurfaces for defence and security

This themed competition is seeking proposals for innovative solutions that will pull ideas from recent breakthroughs in metasurface science into produ...

Read article
SynbiCITE House of Lords Investor Breakfast

The SynbiCITE House of Lords Investor Breakfast was kindly hosted by The Lord Willetts - who instigated the Government’s ‘8 Great Technologies’ progra...

Read article
SynbiCITE welcomes RebelBio to London

We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itse...

Read article
£17 million boost to the UK’s leading life sciences sector

The Chancellor of the Exchequer, Philip Hammond, announced this week £17million new funding will be supplied for UK life science, helping to create real benefits for the NHS and patients.

Read article
Three upcoming Innovation Funding competitions through InnovateUK

​InnovateUK, the UK’s innovation agency, has three forthcoming Innovation Funding Competitions that opened recently.

Read article
CustoMem wins £100K 1st Prize in Bio-start competition

SynbiCITE and Rainbow Seed Fund congratulate CustoMem as winners of the 1st Prize in the Bio-start competition for companies using engineering biology to solve significant global problems.

Read article
Scientists engineer baker's yeast to produce penicillin molecules

The synthetic biologists from Imperial College London have re-engineered yeast cells to manufacture the nonribosomal peptide antibiotic penicillin. In laboratory experiments, they were able to demonstrate that this yeast had antibacterial properties against streptococcus bacteria.

Read article
Bio-start Selects First Cohort: 15 companies join Bio-start’s inaugural synthetic biology accelerator

Bio-start is pleased to announce the 15 companies that will be joining the UK’s first synthetic biology accelerator programme. Applicants from across ...

Read article
Bio-start Competition Announces Additional Cash Prizes and Sponsors

SynbiCITE and Rainbow Seed Fund today announce new sponsors and prizes for the Bio-start competition, designed to commercialise the engineering of biology. The addition of new sponsors increases the number of prizes available to competitors including the free use of laboratory space around the UK.

Read article
Professors Jay Keasling and Chris Voigt Announced as Keynote Speakers at the SynbiCITE & IET Engineering Biology Conference

The 1st International Conference on Engineering Biology, co-founded by SynbiCITE and the Institution of Engineering and Technology (IET), has announced world experts Professor Jay Keasling and Professor Chris Voigt as keynote speakers.

Read article
Future Innovations in Synthetic Biology Forum

The Institute of Child Health in London will host a Synthetic Biology Innovation Forum on 11th October 2016. This event will bring together leading Sy...

Read article